India Phase Change Materials Market, By End-user
| Label | Biopharmaceutical Companies | Hospitals | Medical Laboratories | Others |
|---|---|---|---|---|
| 2019 | 127.87 USD Mn | 107.93 USD Mn | 81.91 USD Mn | 30.24 USD Mn |
| 2020 | 139.42 USD Mn | 116.95 USD Mn | 88.44 USD Mn | 32.32 USD Mn |
| 2021 | 160.63 USD Mn | 133.9 USD Mn | 100.9 USD Mn | 36.5 USD Mn |
| 2022 | 188.57 USD Mn | 156.21 USD Mn | 117.3 USD Mn | 41.99 USD Mn |
| 2023 | 223.16 USD Mn | 183.72 USD Mn | 137.47 USD Mn | 48.69 USD Mn |
| 2024 | 263.7 USD Mn | 215.77 USD Mn | 160.87 USD Mn | 56.36 USD Mn |
| 2025 | 311.97 USD Mn | 253.71 USD Mn | 188.48 USD Mn | 65.31 USD Mn |
| 2026 | 363.79 USD Mn | 294.05 USD Mn | 217.66 USD Mn | 74.58 USD Mn |
| 2027 | 425.02 USD Mn | 341.47 USD Mn | 251.85 USD Mn | 85.31 USD Mn |
| 2028 | 497.91 USD Mn | 397.63 USD Mn | 292.22 USD Mn | 97.83 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The user portion of the India Phase Change Materials Market, By End market is on a steady long-term growth path. Segment value stands at roughly USD 950 Mn in 2026 and is projected to reach USD 1286 Mn by 2028 — a gain of about 35% over the forecast period, translating to a CAGR in the double digits.
- Biopharmaceutical Companies is the biggest of 4 groups as of 2028, at 497. 91M USD (39% of the combined total).
- What the regional split looks like (2026): Biopharmaceutical Companies leads, holding roughly 38% of segment value — the single largest regional share. Hospitals is the second-largest contributor. Medical Laboratories and Others make up the remainder, in descending order.
- By 2028, Biopharmaceutical Companies alone is expected to reach USD 498 Mn, with Hospitals at USD 398 Mn.
Market Dynamics
Biopharmaceutical Companies is the biggest of 4 groups as of 2028, at 497.91M USD (39% of the combined total).
Hospitals follows at 397.63M USD, 20% smaller than Biopharmaceutical Companies.
Biopharmaceutical Companies grows to 497.91M USD by 2028, from 127.87M USD in 2019 — 289% up.
Hospitals climbs from 107.93M USD (2019) to 397.63M USD (2028), a 268% gain.
Medical Laboratories: up 257% over the period, 81.91M USD to 292.22M USD.
Others: 30.24M USD in 2019 to 97.83M USD by 2028, up 224%.
Add every series together and the total reaches 1.29B USD by 2028, 269% above the 2019 combined figure of 347.95M USD.
How To Compare These 4 Groups
This chart compares 4 series side by side, not one trend over time. Read them against each other — the biggest number in the room is not automatically the most important line to follow.
Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.
The most practical way to read this is relative: set the India Phase Change Materials market figures beside other regions or segments of the same market to see where growth is concentrated.
The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2028 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



